Crenezumab Biosimilar – Anti-APP Abeta42 and Abeta40 mAb – Research Grade

Reference:
Size

,

Isotype

IgG4, kappa

Brand

Product type

Clonality

Expression system

Applications

,

Product nameCrenezumab Biosimilar - Anti-APP Abeta42 and Abeta40 mAb - Research Grade
SourceCAS 1095207-05-8
SpeciesHumanized
Expression systemMammalian cells
Purity>85%
BufferPBS buffer PH7.5
Delivery conditionBlue ice (+4°C)
Delivery Time3-5 days if in stock; 3-5 weeks if production needed
Storage conditionstore at -80°C
BrandProteoGenix
Aliases /SynonymsCrenezumab,MABT5102A,RG7412,APP Abeta42 and Abeta40,anti-APP Abeta42 and Abeta40
ReferencePX-TA1269
NoteFor research use only. Not suitable for clinical or therapeutic use.
IsotypeIgG4-kappa
ClonalityMonoclonal Antibody

Description of Crenezumab Biosimilar - Anti-APP Abeta42 and Abeta40 mAb - Research Grade

General information on Anti-APP Abeta42 and Abeta40[Homo sapiens] (Crenezumab) Monoclonal Antibody

Crenezumab has been investigated for the treatment of Alzheimer’s Disease.

Reviews

There are no reviews yet.

REVIEW YOUR PRODUCT

Be the first to review “Crenezumab Biosimilar – Anti-APP Abeta42 and Abeta40 mAb – Research Grade”

Your email address will not be published. Required fields are marked *

Related products

Human APP (18-705) Recombinant Protein
Antigen

Human APP (18-705) Recombinant Protein

PX-P1059 210€
Human IgG4 Isotype Control antibody
Isotype Control

Human IgG4 Isotype Control antibody

PTX17887 180€

Contact us

Got a question or need a quote?
Message us and we’ll get back to you 48 hours or less.






    Cart (0 Items)

    Your cart is currently empty.

    View Products